Skip to main content
Clinical Trials/NCT01516827
NCT01516827
Completed
Not Applicable

Effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) for Children With Post-traumatic Stress Disorder

University of Ulm8 sites in 1 country159 target enrollmentFebruary 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post-Traumatic Stress Disorder
Sponsor
University of Ulm
Enrollment
159
Locations
8
Primary Endpoint
Change from Baseline in Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This multi-site randomized controlled trial compares the effectiveness of Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) as developed by Cohen, Mannarino & Deblinger (2006) with a wait-list condition in a population of children aged 7-16 years who were exposed to traumatic events beyond the age of three years, at least three months ago, and developed Posttraumatic Stress Disorder (PTSD). Primary aims are to provide evidence that TF-CBT exceeds spontaneous remission of posttraumatic stress symptoms and to assess maintenance of treatment gains at 6 and 12 months post-treatment. Secondary aims are to evaluate the effectiveness of TF-CBT in reducing other psychopathology and cognitive distortions of patients and caregivers and to explore moderators and mediators of treatment response. The trial will contribute to implement an evidence-based treatment for traumatized children across a variety of healthcare settings in Germany. The novel aspect is to evaluate the effectiveness of TF-CBT with a broad range of traumatized "real-world" patients in the context of the German mental healthcare system.

Detailed Description

Complete study protocol (in German) available from the PI lutz.goldbeck@uniklinik-ulm.de

Registry
clinicaltrials.gov
Start Date
February 2012
End Date
June 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Ulm
Responsible Party
Principal Investigator
Principal Investigator

Lutz Goldbeck

Head of Section for Psychotherapy Re-search and Behavioural Medicine

University of Ulm

Eligibility Criteria

Inclusion Criteria

  • Age 7-16 years
  • Exposure to a traumatic event (index trauma) after the age of 3 years, at least 3 months before assessment
  • ≥35 points on the Clinician -Administered PTSD Scale for Children and Adolescents (CAPS-CA) total symptom severity score and at least one symptom per PTSD cluster related to the index trauma according to DSM IV diagnostic criteria
  • PTSD should be the main mental health problem, patients with co-morbid mental disorders are included
  • No major brain injury of the child due to the traumatic event (Glasgow Coma Scale \<9 points at primary medical examination)
  • Co-operation of at least one non-offending primary caregiver (improves treatment outcome)
  • Living within reasonable distance (max 1 hour of travel) to the treatment center to allow treatment on a weekly basis (feasibility)

Exclusion Criteria

  • Psychosis
  • Acute suicidality
  • Psychopharmacological medication started or changed up to 6 weeks before first assessment

Outcomes

Primary Outcomes

Change from Baseline in Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)

Time Frame: Change from Baseline at 16 weeks (=end of treatment)

Symptom severity score

Secondary Outcomes

  • Change from Baseline in Schedule for Affective Disorders and Schizophrenia for School Aged Children (K-SADS-PL)(Change from Baseline at 16 weeks (=end of treatment))
  • Change from Baseline in UCLA PTSD Reaction Index (self-report and caregiver report)(Change from baseline at 12 months post-treatment)
  • Change from Baseline in Inventar zur Erfassung der Lebensqualität bei Kindern und Jugendlichen (ILK; Self-report and caregiver report)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Children's Global Assessment Scale (CGAS)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in State-Trait-Anxiety-Inventory (STAI)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)(Change from baseline at 12 months post-treatment)
  • Change from Baseline in Self-report for childhood anxiety related disorders (SCARED; Self-report and caregiver report)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Child Behavior Checklist (CBCL 4/18)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Child Post Traumatic Cognitions Inventory (CPTCI)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Beck Depression Inventory (BDI-II)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Children's Depression Inventory (CDI)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in The Posttraumatic Cognitions Inventory (PTCI)(Change from Baseline at 12 months post-treatment)
  • Change from Baseline in Posttraumatic Diagnostic Scale (PDS)(Change from Baseline at 12 months post-treatment)
  • Change from baselinein Clinician-Administered PTSD Scale for Children and Adolescents (CAPS-CA)(Change from Baseline at 6 monts post-treatment)

Study Sites (8)

Loading locations...

Similar Trials